Table 1.
Case no. | Gender | Age (year) | NFT stage | β‐amyloid stage |
---|---|---|---|---|
Controls | ||||
CTR1 (1′) | M | 75 | I | 0 |
CTR2 (2′) | M | 71 | II | A |
CTR3 (3′) | F | 79 | 0 | B |
CTR4 (4′) | M | 82 | III | 0 |
CTR5 (5′) | M | 77 | II | A |
CTR6 (6′) | F | 75 | 0 | 0 |
CTR7 (7′) | M | 80 | II | A |
CTR8 (8′) | M | 72 | I | B |
CTR9 (9′) | F | 82 | 0 | A |
Alzheimer's disease cases | ||||
AD1 (1′) | F | 87 | V | C |
AD2 (2′) | F | 86 | VI | C |
AD3 (3′) | F | 91 | V | C |
AD4 (4′) | F | 81 | VI | C |
AD5 (5′) | M | 79 | V | C |
AD6 (6′) | F | 100 | VI | C |
AD7 (7′) | M | 89 | V | C |
AD8 (8′) | M | 78 | V | C |
AD9 (9′) | F | 104 | VI | C |
AD10 (10′) | M | 73 | V | C |